||Rapid Review Complete
||In combination with other medicinal products for the treatment of chronic hepatitis C (CHC) in adult patients as part of a triple therapy regimen (co-administered with PegInterferon + Ribavirin) to treat hepatitis C virus (HCV) Genotypes 1 and 4 who are treatment naïve or have previously been treated.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
||Full pharmacoeconomic assessment not recommended when used in triple therapy with peg-interferon and ribavirin.